JCB logo
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1083/jcb.200811035
The Journal of Cell Biology, Vol. 184, No. 1, 31-44
The Rockefeller University Press, 0021-9525 $30.00
© Méjat et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4724K)
Right arrow PDF+supp data (6297K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Méjat, A.
Right arrow Articles by Misteli, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Méjat, A.
Right arrow Articles by Misteli, T.
Related Collections
Right arrowRelated In this Issue article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Lamin A/C–mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy



Alexandre Méjat1, Valérie Decostre2,3, Juan Li4, Laure Renou2, Akanchha Kesari5, Daniel Hantaï2,3, Colin L. Stewart6, Xiao Xiao4, Eric Hoffman5, Gisèle Bonne2,3,7, and Tom Misteli1

1 National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
2 Institut National de la Santé et de la Recherche Médicale, Unite Mixte de Recherche U582, Institut de Myologie, Paris F-75013, France
3 Université Pierre et Marie Curie, University Paris 06, Unite Mixte de Recherche S582, Institut Federatif de Recherche 14, Paris F-75013, France
4 School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
5 Research Center for Genetic Medicine, Children's National Medical Center, Washington, DC 20010
6 Institute of Medical Biology, Immunos, Singapore City 138668, Singapore
7 Assistance Publique, Hôpitaux de Paris, Groupe Hospitalier Pitié Salpêtrière, Unité Fonctionnelle de Cardiogénétique et Myogénétique, Service de Biochimie Métabolique, Paris F-75013, France

Correspondence to Tom Misteli: mistelit{at}mail.nih.gov

The LMNA gene encodes lamins A and C, two intermediate filament-type proteins that are important determinants of interphase nuclear architecture. Mutations in LMNA lead to a wide spectrum of human diseases including autosomal dominant Emery-Dreifuss muscular dystrophy (AD-EDMD), which affects skeletal and cardiac muscle. The cellular mechanisms by which mutations in LMNA cause disease have been elusive. Here, we demonstrate that defects in neuromuscular junctions (NMJs) are part of the disease mechanism in AD-EDMD. Two AD-EDMD mouse models show innervation defects including misexpression of electrical activity–dependent genes and altered epigenetic chromatin modifications. Synaptic nuclei are not properly recruited to the NMJ because of mislocalization of nuclear envelope components. AD-EDMD patients with LMNA mutations show the same cellular defects as the AD-EDMD mouse models. These results suggest that lamin A/C–mediated NMJ defects contribute to the AD-EDMD disease phenotype and provide insights into the cellular and molecular mechanisms for the muscle-specific phenotype of AD-EDMD.


Abbreviations used in this paper: AAV, adeno-associated virus; AChR, acetylcholine receptor; AD-EDMD, autosomal dominant Emery-Dreifuss muscular dystrophy; ALS, amyotrophic lateral sclerosis; Bgt, bungarotoxin; BMD, Becker muscular dystrophy; CMS, congenital myasthenic syndrome; CMV, cytomegalovirus; DCM-CD, dilated cardiomyopathy and conduction system disease; FPLD, Dunnigan-type familial partial lipodystrophy; Hdac9, histone deacetylase 9; LAP2, lamina-associated polypeptide 2; LGMD1B, limb-girdle muscular dystrophy 1B; NMJ, neuromuscular junction; shRNA, short hairpin RNA.

This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related In this Issue article

Lamin A/C deficiency is unnerving
Caitlin Sedwick
J. Cell Biol. 2009 184: 2. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents